Please click here to view the video.
Click the below links for additional resources.
- Defining imaging biomarker cut points for brain aging and Alzheimer's disease
- Recommendations for CSF AD biomarkers in the diagnostic evaluation of MCI
- Defining imaging biomarker cut points for brain aging and Alzheimer's disease
- Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
- Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care